Table 2. Assessment of interaction between Ki67 indices and clinico-pathological variables.
RS | Ki67 Index (Whole-slide) |
P Value | Ki67 Index (Hot-spot) |
P Value |
---|---|---|---|---|
Low | 6.86 | Int. vs Low = 0.012 | 15.84 | Int. vs Low = 0.005 |
Intermediate | 8.33 | High vs Low < 0.001 | 19.21 | High vs Low < 0.001 |
High | 20.21 | High vs Int. < 0.001 | 43.66 | High vs Int. < 0.001 |
Tumor Grade | ||||
1 | 8.15 | 2 vs 1 = 0.297 | 16.49 | 2 vs 1 = 0.704 |
2 | 6.53 | 3 vs 1 < 0.001 | 16.08 | 3 vs 1 < 0.001 |
3 | 7.46 | 3 vs 2 < 0.001 | 33.88 | 3 vs 2 < 0.001 |
ER Score | ||||
ER<5 | 16.96 | 0.004 | 36.98 | 0.002 |
ER = 5 | 7.05 | 16.46 | ||
PgR Score | ||||
PgR<5 | 8.98 | 0.012 | 20.63 | 0.008 |
PgR = 5 | 6.66 | 15.27 | ||
Nuclear Grade | ||||
1 | 7.11 | 2 vs 1 = 0.555 | 17.10 | 2 vs 1 = 0.232 |
2 | 6.85 | 3 vs 1 = 0.046 | 16.06 | 3 vs 1 = 0.129 |
3 | 10.5 | 3 vs 2 < 0.001 | 23.83 | 3 vs 2 < 0.001 |
Mitotic Score | ||||
1 | 6.63 | 2 vs 1 < 0.001 | 15.68 | 2 vs 1 < 0.001 |
2 | 11.95 | 3 vs 1 < 0.001 | 25.99 | 3 vs 1 < 0.001 |
3 | 17.54 | 3 vs 2 = 0.005 | 35.93 | 3 vs 2 = 0.008 |
RS, recurrence score; Int, intermediate-risk group; ER, estrogen receptor; PgR, progesterone receptor.